COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

Thumbnail

Cardiologist-led COVID-19 study to focus on protecting healthcare workers

The Duke Clinical Research Institute (DCRI) has launched a new study aimed at evaluating how COVID-19 is impacting the health of physicians throughout the United States. Researchers will also assess the potential ability of hydroxychloroquine to limit infections among high-risk healthcare providers.

Thumbnail

Stroke surgeons issue warning to public: Time is still brain during COVID-19 pandemic

The COVID-19 pandemic is changing patient care at hospitals all over the world, but a group of leading surgeons wants to make sure people aren’t ignoring stroke symptoms due to fears over getting the virus.

Thumbnail

Hospitals margins fell as COVID-19 pandemic ramped up

U.S. hospitals were already facing falling margins when the COVID-19 pandemic began to ramp up in the nation.

Thumbnail

Where COVID-19 is hitting state economies the hardest

Louisiana is the most exposed state economy when it comes to the new coronavirus, COVID-19.

Thumbnail

CMS eases regulations for COVID-19 response

CMS is allowing healthcare providers to react to the COVID-19 pandemic with greater flexibility by loosening some federal requirements and issuing sweeping new rules.

Hypertension and COVID-19: 4 key things patients should know

What, exactly, do patients need to know about the relationship between hypertension and COVID-19?

Thumbnail

HHS accelerates clinical trials for COVID-19 vaccines

HHS is speeding up the development and manufacturing of COVID-19 vaccines by partnering with Johnson & Johnson-owned Janssen Research and Development and Moderna Therapeutics.

Thumbnail

EuroHeartCare 2020 canceled over COVID-19 concerns

The event was scheduled to occur June 4-6 in Seville, Spain. It has been rescheduled for June 17-19, 2021.